Core Insights - The Health and Wellness Services Special Topic will be held at the Beijing Shougang Park from September 10 to 14, 2025, under the theme "Intelligent Leadership for a Healthy Life" [1] - The event will feature a specialized exhibition and will concurrently host nearly 20 various meetings, forums, and supporting activities, including the "Capital International Medical Conference" [1] - The participation rate of Fortune Global 500 and industry-leading companies reached 54%, with an internationalization rate of 53% [1]

Group 1: Core Themes of the Exhibition - The 25th China International Investment and Trade Fair opened in Xiamen, showcasing Heilongjiang's regional characteristics and industrial vitality through four core themes: ice and snow, technology, agriculture, and China-Russia cooperation [1][12][16] - The agricultural exhibition area attracted significant attention, featuring products from Heilongjiang's fertile black soil, including rice, oil, and rare specialties, which captivated visitors [1][3][15] Group 2: Agricultural Highlights - The North China Agricultural Group's booth displayed high-quality long-grain fragrant rice and non-GMO soybean oil, emphasizing the purity of Heilongjiang's agricultural products [3][5] - The Daxing'anling region showcased organic mushrooms and wild berry products, highlighting the unpolluted environment of their production base [5][7] - Other notable products included fresh cranberries and beef products from Heihe, which drew considerable interest from attendees [7][15] Group 3: Technological Innovations - The technology exhibition featured innovative products such as a natural lighting curtain that enhances indoor lighting efficiency significantly [8][10] - The Intelligent Vision Medical Robot, designed for retinal surgeries, demonstrated high precision and real-time monitoring capabilities, attracting considerable attention [10][15] - High-end electric motors and advanced materials were also showcased, reflecting Heilongjiang's strength in technology and innovation [10][16] Group 4: China-Russia Cooperation - The China-Russia cooperation area highlighted the theme of building a new highland for northern openness, with Russian chocolates and cookies drawing visitors [12][16] - The Black River Longfei Investment Group reported over 30 potential business collaborations on the first day of the fair, exceeding expectations [12][16] Group 5: Ice and Snow Economy - The ice and snow exhibition area became a popular spot, featuring stylish down jackets and commemorative items related to the Winter Olympics, embodying the region's cultural charm [14][16] - The theme "Green Water and Green Mountains are Golden Mountains and Silver Mountains" was prominently displayed, emphasizing the economic potential of the ice and snow industry [14][16]

Core Viewpoint - The company has made significant advancements in the artificial intelligence sector by developing a self-evolving multimodal intelligent architecture, which has led to the creation of a revolutionary intelligent health examination report system that is currently being trialed by partner institutions [1] Group 1: Technological Advancements - The new system utilizes a top-tier expert thinking chain model that continuously learns and updates medical frontier knowledge [1] - It comprehensively analyzes user health examination images, tests, and medical history data to generate personalized health reports [1] - The system significantly reduces misdiagnosis and missed diagnosis rates by eliminating human biases and accurately identifying complex health risks [1] Group 2: Industry Impact - The transition from traditional health examinations to intelligent examinations represents not only a technological improvement but also an industrial transformation [1] - The system enables real-time collaboration with remote medical nodes, generating expert-level reports in seconds [1] - It ensures that primary healthcare institutions have access to the analytical capabilities of top-tier hospitals, allowing high-quality medical resources to be accessible without boundaries [1]

Core Insights - The company has made significant advancements in the artificial intelligence sector by developing an autonomous multi-modal intelligent agent architecture based on its proprietary optimized large model [1] - A revolutionary intelligent health examination report system has been created, which is currently in trial use at partner institutions [1] Company Developments - The new system employs a top-tier expert thinking chain model that continuously learns and updates medical frontier knowledge in real-time [1] - It comprehensively analyzes user health examination images, tests, and medical history data to generate personalized health reports [1] - The system significantly reduces misdiagnosis and missed diagnosis rates by eliminating human biases and accurately identifying complex health risks [1] Industry Impact - The transition from traditional health examinations to intelligent health examinations represents not only a technological improvement but also an industrial transformation [1] - Each health examination data point is transformed into an intelligent guide for precise health management, ensuring that high-quality medical resources are accessible without boundaries [1] - The system enables real-time collaboration with remote medical nodes, generating expert-level reports in seconds, thus providing grassroots institutions with the analytical capabilities of top-tier hospitals [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚 賴該等內容而引致之任何損失承擔任何責任。 CONCORD HEALTHCARE GROUP CO., LTD. 美中嘉和醫學技術發展集團股份有限公司 （股份代號：2453） 自願公告 自研多模態智能體系統進展 本公告乃由美中嘉和醫學技術發展集團股份有限公司（「本公司」）董事會（「董事 會」）自願刊發。 董事會欣然宣佈，本公司在人工智能領域再度取得重要進展，基於自主研發的優 化大模型，成功構建了自主進化的多模態智能體架構，打造了顛覆傳統的智能體 檢報告系統，並已在合作機構開始試用。 該系統採用頂級專家思維鏈模式，持續學習並實時更新醫學前沿知識，全面分析 用戶體檢影像、檢驗、病史等多模態數據，生成個性化健康報告。通過消除人為 偏差，精準定位復合型健康風險，該系統極大降低誤診率、漏診率，並支持遠程 醫療節點實時聯動，秒級完成專家級報告生成，確保基層機構享有三甲級醫院分 析能力，令優質醫療資源無界觸達。 由傳統體檢到智能體檢，不僅是技術改進，更是一場產 ...

Core Points - The China Securities Regulatory Commission (CSRC) has approved the initial public offering (IPO) registration application of Shanghai Jianda Zhi New Medical Technology Group Co., Ltd [1] - The approval allows the company to issue stocks and list on the Growth Enterprise Market [1] - The company must strictly adhere to the submitted prospectus and underwriting plan during the stock issuance process [1] Regulatory Details - The approval is valid for 12 months from the date of registration [1] - The company is required to report any significant events to the Shenzhen Stock Exchange before the completion of the stock issuance [1]

Core Viewpoint - The company has established and improved its governance structures, including the shareholders' meeting, board of directors, supervisory board, independent directors, and board secretary system, in preparation for its initial public offering on the Growth Enterprise Market [1][2][4][5][6]. Shareholders' Meeting System - The company has adopted its Articles of Association and rules for the shareholders' meeting, establishing a standardized system that allows shareholders to exercise their rights in accordance with the Company Law and the Articles of Association [1]. - The shareholders' meeting has convened 11 times during the reporting period, adhering to legal and regulatory requirements to protect the rights of the company and its shareholders [1]. Board of Directors System - The board of directors, consisting of 9 members, is responsible for managing the company's operations and is accountable to the shareholders' meeting [2][3]. - The board has held meetings in compliance with the Articles of Association and has effectively participated in decision-making regarding profit distribution, listing plans, and the appointment of senior management [3]. Supervisory Board System - The supervisory board, composed of 3 members, serves as the company's oversight body, ensuring the protection of the rights of the company, shareholders, and employees [4]. - The supervisory board has convened 16 meetings during the reporting period, fulfilling its responsibilities in accordance with legal and regulatory requirements [4]. Independent Directors System - The company has appointed 3 independent directors, ensuring that they constitute at least one-third of the board, and has established guidelines for their roles and responsibilities [5]. - Independent directors actively participate in decision-making and have contributed to the protection of minority shareholders' rights and the overall governance structure [5]. Board Secretary System - The board secretary is responsible for information disclosure, investor relations, and organizing board and shareholders' meetings, ensuring compliance with relevant regulations [6]. - Since the appointment of the board secretary, the company has maintained effective communication with shareholders and has contributed to the improvement of the governance structure [6].

上海建发致新医疗科技集团股份有限公司（以下简称"公司"）申请首次公 开发行股票并在创业板上市，根据《首次公开发行股票注册管理办法》《公开发 行证券的公司信息披露内容与格式准则第 58 号——首次公开发行股票并上市申 请文件》等有关规定，现将审计委员会及其他专门委员会的设置情况说明如下： 一、专门委员会的建立健全情况 公司董事会下设战略、提名、薪酬与考核、审计四个专门委员会。专门委员 会成员全部由董事组成，其中薪酬与考核委员会、提名委员会、审计委员会中独 立董事占多数并担任召集人，审计委员会中担任召集人的独立董事是会计专业人 士。 上海建发致新医疗科技集团股份有限公司 关于审计委员会及其他专门委员会的设置情况说明 深圳证券交易所： 《董事会提名委员会工作细则》 《董事会薪酬与考核委员会工作细则》 《董 事会审计委员会工作细则》的议案，对战略委员会、提名委员会、薪酬与考核委 员会、审计委员会的人员组成、职责权限、评审及工作程序、议事规则等作出了 规定。自董事会各专门委员会设立至今，各委员能切实履行职责，保障了公司的 规范运行。 （以下无正文，为《上海建发致新医疗科技集团股份有限公司关于审计委员会及 其他专门委员会 ...

Group 1: Investor Relations Management - The company has established a comprehensive information disclosure system to ensure transparency and protect investors' rights, including the development of various management regulations such as the "Independent Director Work Guidelines" and "Investor Relations Management System" [1][2] - The company has set up a dedicated office for investor relations, led by the board secretary, to facilitate communication with investors and provide necessary information [1][2] - Future plans include enhancing communication with investors, particularly public investors, and establishing a stable and harmonious relationship through the implementation of the "Investor Relations Management System" [2][3] Group 2: Dividend Distribution Policy - The company aims to implement a stable and sustainable profit distribution policy, prioritizing cash dividends while considering long-term growth and operational sustainability [3][4] - Cash dividends will be prioritized, with a minimum of 30% of the average distributable profits over three years to be distributed if conditions are met [4][5] - The board will consider various factors, including industry characteristics and major investment plans, when proposing differentiated cash dividend policies [4][5] Group 3: Shareholder Voting Mechanism - The company has adopted a cumulative voting system for the election of directors and supervisors, allowing shareholders to concentrate their voting rights [9][10] - All proposals at the shareholder meeting will be voted on individually, ensuring transparency and accountability in decision-making [9][10] - The company will provide online voting options to facilitate participation from shareholders, particularly small and medium-sized investors [11]

Core Viewpoint - Shanghai Jianfa Zhixin Medical Technology Group Co., Ltd. has received approval for its initial public offering (IPO) of ordinary shares (A shares) and listing on the ChiNext board, with the application approved by the Shenzhen Stock Exchange and registered by the China Securities Regulatory Commission [1][19]. Group 1: IPO Details - The company plans to issue 63,193,277 new shares, representing approximately 15.00% of the total share capital post-IPO [19]. - The IPO will be conducted through a combination of strategic placements, offline inquiries to qualified investors, and online offerings to public investors holding non-restricted A shares or depository receipts [19]. - The offering price will be determined based on the median and weighted average of bids from offline investors, excluding the highest bids [3][19]. Group 2: Subscription Process - Offline subscription will occur from 9:30 AM to 3:00 PM, while online subscription will be from 9:15 AM to 11:30 AM and 1:00 PM to 3:00 PM on September 16, 2025 [2]. - Investors do not need to pay subscription funds at the time of bidding [2]. - The strategic placement will involve senior management and core employees, as well as large enterprises with strategic cooperation relationships [3][19]. Group 3: Investor Requirements - Qualified offline investors must submit pricing basis and proposed prices or price ranges before participating in the inquiry [4][8]. - The minimum proposed subscription quantity for offline investors is set at 2.5 million shares, with increments of 1 million shares thereafter [5][6]. - Investors must ensure that their proposed subscription amounts do not exceed their total assets as of the last month-end prior to the inquiry [6][10]. Group 4: Issuance and Allocation - The final allocation of shares will be based on effective subscription multiples, industry valuation levels, and the company's fundamentals [11][12]. - The offline issuance will adopt a proportionate lock-up method, with 90% of shares being freely tradable upon listing and 10% subject to a 6-month lock-up period [13][19]. - The underwriting will be conducted on a balance underwriting basis by the lead underwriter, CITIC Securities [19][20].